Johnson & Johnson to Test a Pioneering HIV Vaccine: Brainstorm Health

Happy Friday, readers! Johnson & Johnson doesn’t just want to treat HIV—it wants to prevent against it altogether with an experimental vaccine. The U.S. drug giant announced Friday that will test out the vaccine in the U.S. and Europe this year, according to CNBC. If it proves successful—following testing on thousands of men who have […]

Drug-Company Patents vs. the Public Good: Should the NIH Break This Medication Patent?

Should a biotech giant holding a valuable patent be forced to give it up if doing so would serve the public good? That’s the mounting debate over Gilead Sciences’ hold on an HIV prevention treatment, which some say is too expensive and should be available to all. Truvada, which is made by California-based Gilead Sciences, […]